News

Eli Lilly & Company (NYSE:LLY) ranks among the best set-it-and-forget-it stocks to buy. On June 27, UBS kept its Buy rating ...
ASX health stocks jumped 1.6% over five days, with wound management house Tetratherix making its ASX debut, breaking the IPO ...
Eli Lilly and Company (NYSE:LLY) is one of the 13 best blue-chip stocks to buy, according to analysts. On June 30, RBC ...
Wall Street analysts remain bullish on Eli Lilly, boasting an Average Brokerage Recommendation (ABR) of 1.46, largely between ...
The NYLI Winslow Large Cap Growth Fund outperformed the benchmark for the quarter. Outperformance also reflected the waning ...
Joe Gebbia, a confidant of the technology billionaire and a Tesla director, is also a leader of the federal cost-cutting team ...
Neurizon has inked a global licensing deal with Elanco Animal Health and affiliates for monepantel, the active pharmaceutical ...
COPENHAGEN (Reuters) -Novo Nordisk’s top executives ignored internal warnings that the company was not sufficiently prepared ...
As Medadvisor's divestment deal today attests, foreign acquirers are on the hunt for undervalued local assets.
Hardman Johnston Global Advisors, an investment management company, released its “Hardman Johnston Global Equity Strategy” ...